JPMorgan European Growth &ome (CHIX:JEGIL) Research & Development: £0.0 Mil (TTM As of Mar. 2026)


CHIX:JEGIL JPMorgan European Growth & Income PLC CHIX:JEGIL
58 GF Score
Price £0.97
GF Value £1.02
! 5 Warning Signs
View Full Analysis

What is JPMorgan European Growth &ome Research & Development?

JPMorgan European Growth &ome CHIX:JEGIL 58 Research & Development is £0.0 Mil as of Mar. 2026. GuruFocus rates CHIX:JEGIL with a GF Score™ of 58/100 and a GF Value™ of £1.02. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. JPMorgan European Growth &ome's Research & Development for the six months ended in Mar. 2026 was £0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was £0.0 Mil.

JPMorgan European Growth &ome  (CHIX:JEGIl) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

JPMorgan European Growth &ome Research & Development Related Terms

JPMorgan European Growth &ome Research & Development Historical Data

* Premium members only.

The historical data trend for JPMorgan European Growth &ome's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JPMorgan European Growth &ome Research & Development Chart

JPMorgan European Growth &ome Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

JPMorgan European Growth &ome Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:JEGIL
58GF Score
JPMorgan European Growth & Income PLC CHIX:JEGIL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JPMorgan European Growth &ome Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.0 Mil mean?
JPMorgan European Growth &ome (CHIX:JEGIL) has a Research & Development of £0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on JPMorgan European Growth &ome and its competitors.
Is JPMorgan European Growth &ome's Research & Development too high?
JPMorgan European Growth &ome's current Research & Development is £0.0 Mil. Overall, JPMorgan European Growth &ome has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does JPMorgan European Growth &ome's Research & Development compare to BLK and BX?
JPMorgan European Growth &ome's Research & Development of £0.0 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on JPMorgan European Growth &ome and its competitors. JPMorgan European Growth &ome's current Research & Development is £0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JPMorgan European Growth &ome stock overvalued right now?
JPMorgan European Growth &ome (CHIX:JEGIL) has a current Research & Development of £0.0 Mil. The stock's GF Value™ is £1.02, compared to a current price of £0.97 — trading 5.1% below its estimated fair value. The current Research & Development is £0.0 Mil. JPMorgan European Growth &ome's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For JPMorgan European Growth &ome (CHIX:JEGIL), the current Research & Development is £0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JPMorgan European Growth &ome (CHIX:JEGIL) Overvalued in 2026?

Based on GuruFocus' analysis, JPMorgan European Growth &ome stock appears to be undervalued. The current stock price of £0.97 is trading 5.1% below its estimated GF Value™ of £1.02.

Key valuation signals for CHIX:JEGIL:

  • Research & Development: £0.0 Mil
  • GF Value™: £1.02 vs. price of £0.97 (5.1% below fair value)
  • GF Score™: 58/100 with 5 warning signs

No single metric tells the full story. See the CHIX:JEGIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JPMorgan European Growth &ome Business Description

Other Exchanges JEGI:UK
Address 60 Victoria Embankment, London, GBR, EC4Y 0JP
JPMorgan European Growth & Income PLC is a trust that invests in a region of well governed companies which is managed by experienced fund managers with a successful European stock picking track record aiming to outperform in different economic, market and style environments. Its investment objective is that it aims o provide capital growth and a rising share price over the longer term from Continental European investments by taking carefully controlled risks through an investment method that is clearly communicated to shareholders. Currency exposure is predominantly hedged back towards the benchmark.
58GF Score

Get the complete analysis for CHIX:JEGIL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.97
Price
£1.02
GF Value